Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

354
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
354
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

360
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
360
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

377
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
377

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Science advances·2026
Same author

Glomerular Endothelial Rarefaction Associated With Hypoxic Neutrophils Marks Renal Pathology Activity in Lupus Nephritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Corrigendum to Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression, Cancer Treatment and Research Communications 46 (2026) 101109.

Cancer treatment and research communications·2026
Same author

Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel events.

Pathology, research and practice·2026
Same author

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Clinical outcomes of peritoneal dialysis in patients with chronic liver and kidney failure: A single-center study.

Clinical nephrology·2026

Related Experiment Video

Updated: Sep 28, 2025

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K

A Model To Estimate Glucose Absorption in Peritoneal Dialysis: A Pilot Study.

Suman Krishna Kotla1,2, Ashish Saxena3, Ramesh Saxena1

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Kidney360
|April 4, 2022
PubMed
Summary

A new model accurately estimates glucose absorption in peritoneal dialysis (PD) patients, crucial for managing metabolic effects and weight gain in automated PD. This tool aids in calculating caloric load for improved patient outcomes.

Keywords:
dialysisglucoseglucose absorptionperitoneal dialysispilot projects

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.1K
A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

12.0K

Related Experiment Videos

Last Updated: Sep 28, 2025

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.1K
A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

12.0K

Area of Science:

  • Nephrology
  • Metabolic Medicine
  • Biostatistics

Background:

  • Glucose absorption during peritoneal dialysis (PD) can lead to adverse metabolic effects.
  • Contemporary automated PD (aPD) uses shorter dwell times than traditional continuous ambulatory PD, altering glucose absorption dynamics.
  • Peritoneal membrane characteristics and dwell time significantly influence small-solute transport, including glucose.

Purpose of the Study:

  • To develop and validate a simple, accurate model for estimating daily glucose absorption in patients undergoing PD.
  • To assess the caloric load from glucose absorption in patients on various PD modalities.
  • To provide a tool for clinicians to better manage metabolic complications associated with PD.

Main Methods:

  • Utilized data from the peritoneal equilibration test (PET) in a pilot study of six PD patients.
  • Developed a nonlinear, least-squared regression model using R programming, incorporating PET parameters (D2/D0, D4/D0) to predict glucose absorption.
  • Validated the model by comparing estimated glucose absorption with directly measured values and subsequently analyzed data from an independent cohort of 11 ESKD patients on different PD modalities.

Main Results:

  • The developed model showed high accuracy, with estimated glucose absorption closely matching directly measured values (88.12±28.9 g/d vs. 89.7±28.8 g/d, P>0.05).
  • Analysis of an independent cohort revealed a mean daily glucose absorption of 62.7±24.5 g, which is lower than previously reported and influenced by dwell times and membrane characteristics.
  • The study confirmed that glucose absorption varies significantly among PD patients and is dependent on individual factors.

Conclusions:

  • A validated, simple regression model effectively estimates glucose absorption and caloric load in contemporary PD patients.
  • Accurate estimation of caloric load can be integrated into daily nutritional management to mitigate hyperglycemia and weight gain.
  • Improved management of glucose absorption and caloric intake holds the potential to enhance overall patient outcomes in PD.